A roundup of manufacturing and service expansions.
Cambridge, MA (Sept. 18)—Genzyme broke ground on an expansion of its flagship manufacturing facility at Allston Landing in Boston. The $150-million project is focused on adding space for manufacturing support functions and will allow for the creation of 90 jobs.
Somerset, NJ (Sept. 17)—Catalent Pharma Solutions, a provider of outsourced clinical and commercial packaging services, will expand its temperature-controlled warehouse in Bolton, United Kingdom, to meet increased customer demand for clinical-supply services, especially cold-chain storage and distribution. This expansion involves a purpose-built extension of the existing facility and is expected to be operational in June 2008. Planned features for the temperature-controlled warehouse include floor space of more than 7500 ft2, more than 2700 controlled ambient storage locations, and a 320-pallet refrigerator.
St. Louis, MO (Sept. 12)—Sigma-Aldrich will invest in a site at the Wuxi-New District Park located northwest of Shanghai, China, for its new Asia-Pacific manufacturing hub. Sigma-Aldrich expects to initially invest $25 million to acquire land rights and construct its first phase, which includes a large-scale, non-CGMP, multipurpose organic manufacturing facility dedicated to supporting its SAFC fine chemicals business unit. Construction of the new plant is set to start by the end of 2007. When fully developed, the manufacturing plant is expected to produce raw materials, key intermediates, and final products in support of SAFC's businesses. The site will also contain analytical, packaging, and warehousing facilities.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.